Search Results
281 items found for "Structure Therapeutics"
- Ep 74 with Dr. Daniel Wacker
Ray Stevens in 2013 solving several GPCR crystal structures, including that of the first serotonin receptor Bryan Roth where I established GPCR structural biology and learned the ins and outs of molecular pharmacology started my own lab at the Icahn School of Medicine at Mount Sinai in NYC, where I have been working on structure-function
- From odor to oncology: non-canonical odorant receptors in cancer
These findings shed light on the potential of non-canonical odorant receptors as therapeutic targets these chemoreceptors and various types of cancer, potentially paving the way for innovative odor-based therapeutics Ultimately, this review discusses the potential development of novel therapeutic strategies targeting GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Gi/o GPCRs drive the formation of actin-rich tunneling nanotubes in cancer cells via a Gβγ/PKCα/FARP1/Cdc42 axis
filopodia-like elongated projections connecting adjacent cells, known as tunneling nanotube (TNT)-like structures Consistent with the established role of Rho small GTPases in the formation of actin-rich projecting structures into the intricate signaling pathways governing the generation of specialized actin-rich elongated structures GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- C5aR2 receptor: The genomic twin of the flamboyant C5aR1
In addition, the structure of C5aR2 and its interaction specificity toward C5a is not structurally elucidated The current study has attempted to close the gap by generating highly refined model structures of C5aR2 GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Ep 59 with Dr. Nicola J. Smith
Nicola J Smith is an expert in molecular pharmacology with a track record in exploring GPCR structure-function orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic
- Ep 16 with Dr. Aaron Sato
He earned his Ph.D. at the Massachusetts Institute of Technology, where he studied MHC class II structure-function record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics
- Ep 77 with Martin Audet
Martin Audet Structural biologist, pharmacologist, and a professor of pharmacology at Université de Sherbrooke the AudetLab located at the Institute of Pharmacology of Sherbrooke and is an emerging leader in the structural
- The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy
Despite their crucial role in regulating antitumor immunity and tumorigenesis, therapeutic applications GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- GPCR Retreat Logo Contest | Dr. GPCR Ecosystem
embody the multifaceted nature of GPCRs, showcasing their complexity, versatility, and potential for therapeutic reflects the diverse fields of study encompassing GPCR research, such as biochemistry, pharmacology, structural
- Ep 135 with Dr. Katarzyna Marcinkiewicz
Communications, which she joined in April 2020, following three years on the editorial teams of Nature Structural Katarzyna handles submissions in structural biology, biophysics and biochemistry, with a particular focus
- CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitus
Moreover, we utilize a combination of ex vivo and in vivo approaches to explore the functional and therapeutic Our mechanistic studies reveal that the therapeutic effects of CB2 are mediated through activation of GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Regulator of G protein signaling 16 restrains apoptosis in colorectal cancer through disrupting TRAF6-TAB2-TAK1-JNK/p38 MAPK signaling
cancer (CRC) remains a major global cause of cancer-related mortality, lacking effective biomarkers and therapeutic Revealing the critical pathogenic factors of CRC and the underlying mechanisms would offer potential therapeutic proteins in CRC, identifying Regulator of G protein signaling 16 (RGS16) as a prospective diagnostic and therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Dopamine-Mediated Motor Recovery after Ischemic Stroke
The Tiberi Lab pursues the study of the molecular, structural, pharmacological and signaling features We hope our research will aid in the development of new therapeutic interventions for the alleviation
- Itaconate in host inflammation and defense
regulation, discuss its target proteins and mechanisms, and conjecture a rationale for developing ITA-based therapeutics GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Ep 40 with Dr. Brian Bender
Brain’s work there primarily focused on structure prediction of GPCRs from sparse experimental data. of California in San Francisco to continue his training as a postdoctoral researcher where he used structural
- GPR37 promotes colorectal cancer against ferroptosis by reprogramming lipid metabolism via p38-SCD1 axis
pro-carcinogenic effect of GPR37 in primary CRC and suggest that targeting GPR37 could be a potential therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Metabolic crosstalk: Extracellular ATP and the tumor microenvironment in cancer progression and therapy
This review explores e-ATP metabolism, its purinergic signaling, and therapeutic strategies targeting Tags Extracellular ATP (e-ATP) , Immunosuppression , Purinergic receptors , Purinergic signaling , Therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- GPCR signaling contributes to immune characteristics of microenvironment and process of EBV-induced lymphomagenesis
Therapeutic targeting CCR1 showed promising efficacy with EBV eradication, T-cell activation, and lymphoma GPCR-mediated malignant progression and translated sensors of viral molecules into EBV-specific anti-cancer therapeutics GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
One aspect of PDAC is elevated ATP levels, pointing to the purinergic axis as a potential attractive therapeutic work elucidates a novel GPCR-integrin interaction in cancer invasion, highlighting its potential for therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Ep 75 with Vaithish Velazhahan
His Ph.D. work has been focused on understanding the structure and activation of Class D fungal GPCRs developed novel tools and methodologies to study fungal GPCRs which allowed the determination of the first structures
- Session IX / Technology capsule: Light on aGPCR signaling and function | Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
overcome these obstacles by producing high-quality antibodies that more accurately mimic natural protein structures This approach contrasts with other antigen forms like peptides or DNA, which face limitations in structural
- Chemoattractant receptor signaling in humoral immunity
signaling in the context of humoral immunity and discuss the potential of the COMMD3/8 complex as a therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Ep 61 with About Dr. Marta Filizola
The overall goal of her research program is to obtain rigorous mechanistic insights into the structure To this end, her lab uses several computational structural biology tools and rational drug design approaches
- Ep 53 with Dr. Timo De Groof
During his master's studies, he specialized in Biomedical Biotechnology and Structural Biology/Biochemistry nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic
- Biochemical pharmacology of adenylyl cyclases in cancer
of different components in AC-related signaling could potentially lead to the development of novel therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- GPCRs and fibroblast heterogeneity in fibroblast-associated diseases
identification, polypharmacology, and effective personalized medicine approaches to achieve better therapeutic GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Mechanistic exploration of bioactive constituents in Gnetum gnemon for GPCR-related cancer treatment through network pharmacology and molecular docking
Functional enrichment analysis revealed the promising therapeutic effects of these targets on GPCRs-related This study presents a novel approach for comprehending the therapeutic mechanisms of GG-derived active GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural
- Single cell G-protein coupled receptor profiling of Transcription factor 21 expressing activated kidney fibroblasts
matrix in chronic kidney disease (CKD) and G-protein coupled receptors (GPCRs) are the most druggable therapeutic Study of GPCRs expressed by these cells may identify new opportunities for CKD therapeutics. " Authors GPCRs in Neuroscience GPCRs in Cardiology, Endocrinology, and Taste GPCRs in Oncology and Immunology Structural